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Abstract: The wear-debris particles released by shearing forces during dental implant insertion may
contribute to inflammatory reactions or osteolysis associated with peri-implantitis by stimulating
inflammasome-activation. The study aim was to examine cytotoxic and pro-inflammatory effects
of titanium (TiO2) and zirconia (ZrO2) particles in macrophages regarding their nature/particle
concentration over time under sterile lipopolysaccharide (LPS) inflammation. Macrophages were
exposed to TiO2 and ZrO2 particles (≤5 µm) in cell culture. Dental glass was used as inert control
and LPS (1 µg/mL) was used to promote sterile inflammation. Cytotoxicity was determined using
MTT assays and cytokine expression of TNF-α, IL-1β and IL-6 was evaluated by qRT-PCR. Data were
analyzed using Student’s t-test and ANOVA (p ≤ 0.05). Cytotoxicity was significantly increased
when exposed to higher concentrations of glass, TiO2 and ZrO2 (≥10
7 particles/mL) compared to
controls (p ≤ 0.05). Macrophages challenged with TiO2 particles expressed up to ≈3.5-fold higher
upregulation than ZrO2 from 12 to 48 h. However, when exposed to LPS, TiO2 and ZrO2 particle-
induced pro-inflammatory gene expression was further enhanced (p ≤ 0.05). Our data suggest that
ZrO2 particles produce less toxicity/inflammatory cytokine production than TiO2. The present study
shows that the biological reactivity of TiO2 and ZrO2 depends on the type and concentration of
particles in a time-dependent manner.
Keywords: inflammation; cytokines; macrophage; peri-implantitis; titanium; zirconia
1. Introduction
Dental implants have been a breakthrough healthcare solution since their invention by
Brånemark in the 1960s, and are currently a worldwide standard treatment for partial or to-
tal tooth loss [1–3]. Dental implant use on edentulism treatment routinely presents a success
rate of more than 90% [4–6]. Nonetheless, peri-implantitis prevalence has been rising on
account of mucosa biofilm-related inflammation and alveolar bone dismantling [7,8]. Fol-
lowing previous studies, peri-implantitis prevalence rates typically range from 11% to 53%
for patients and from 5% to 37% for implants [9–13]. Strong associations have been found
between implant surface oral biofilm microbiota and the host immune response, which
leads to the inflammatory pathogenesis of peri-implantitis [14,15]. In fact, immunopatho-
logical events that regulate peri-implantitis development were shown to closely mirror
those of periodontitis, and even oral bacterial species were found to have strong similarities
to periodontitis [16,17]. In addition, peri-implantitis or mucositis may occur on account of
previously well-established risk factors, such as smoking, non-controlled type 2 diabetes
mellitus, lack of oral hygiene or maintenance, history of periodontitis and obesity [18,19].
These indicators suggest that systemic metabolic disorders should not be neglected when
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placing a dental implant since they can potentially contribute to peri-implantitis develop-
ment [20,21]. Titanium-based alloys are considered the gold standard material due to its
remarkable mechanical (i.e., oxidation/corrosion resistance) and biological (bone biocom-
patibility) properties [22,23]. Within the four commercially available pure titanium grades
(1 to 4), Ti-6Al-4V is the most widely used for dental implants with the highest oxygen
content and best overall mechanical strength. For improving corrosion resistance and re-
ducing elasticity, the zirconium alloy element was added to titanium, creating a stabilizing
effect in the β structure (metastable or stable) [22,23]. Despite its biocompatible advantages,
questions about titanium sensitivity have been notably arising and it is detected with an
estimated prevalence of 0.6% [24]. Previous studies indicated clinical titanium hypersensi-
tivity [24,25]. Animal studies showed accumulation of titanium particles in lymph nodes,
lungs and bones after implant placement [26]. In addition, titanium in contact with fluoride
or metal alloys in the saliva demonstrated corrosion [27]. However, the clinical relevance
of these observations remains unclear. As an alternative to titanium alloy implants, the
zirconium dioxide ceramics have been introduced with esthetic improved properties. The
currently used tetragonal zirconia (yttrium oxide (yttria)-stabilized zirconia) is the ceramic
of choice for dental implants [22,23,28]. The white, opaque color of zirconia, along with
good established biocompatibility and low affinity to bacterial plaque, make it a material
of interest in dental implantology. Zirconia alloys also present significant physical and
mechanical properties as an advanced dental implant material, such as fracture resistance,
high flexural strength and corrosion resistance [29]. However, zirconium was shown to
slowly develop roughness with time by possible transformation of the tetragonal phase
into monoclinic phase, thus inducing progressive material deterioration [29]. Aging is
another critical process that can result in microcracking and material stress and can be influ-
enced by macroscopic shape and the surface characteristics during implant production [29].
The structure of the titanium and zirconium alloys’ surface may substantially affect the
implant biocompatibility, and in the long-term prospect, they could also have potential
toxic effects and cause allergic reactions. Still requiring further particular consideration is
the fact that an immunological response may partially also in part occur due to metal or
foreign-body particles released by abrasion from shearing forces during dental implant
positioning, abutment–implant interface micromovements and biocorrosion [30–34]. Both
titanium and zirconium particle elements were histologically present in peri-implantitis
mucosa [35,36]. A higher level of metal-like particles was also detected in patients with
peri-implantitis lesions [35,36]. Thus, implant wear material particles may indeed play a
key role in the implant hypersensitivity or allergic reactions, yet remain currently little
understood. The lack of research in this area is not accidental. The design requirements for
such a systematic in vitro or in vivo examination are stringent and generally difficult to
meet. Many histological studies have demonstrated that peri-implantitis human biopsy
material presented metal-like debris or particles and associated inflammatory tissue cell
infiltrate around the implant [21,30,37]. However, the same detectable metal particles were
also observed at healthy implant sites, which makes it unclear whether the peri-implantitis
pathogenesis is associated with the type of particles originating from titanium or zirconia
ceramic [35]. Even so, several in vitro studies for the most part confirmed evidence that
micro- or nano-particles of common titanium implant alloys may induce cell cytotoxicity
and pro-inflammatory augmentation [38–41]. There is also limited data showing yttria-
stabilized tetragonal zirconia particles as one of the implant-released materials that may
cause similar inflammatory or cytotoxic effects [42]. This fundamentally disputes the
potential function of zirconia particles in the establishment of peri-implantitis. Many cy-
tokines, such as IL1-β, IL-6 and TNFα, play a crucial role in the innate immune system after
macrophage toll-like receptors are activated by bacterial pathogens [43]. It has been shown
that various crystal particles (silica, cholesterol, aluminum, asbestos) can mediate activation
and release of IL1-β in macrophages [44–47]. Moreover, endotoxin bacterial products or
lipopolysaccharides (LPS) from pathogenic periodontal bacteria, such as Aggregatibacter
actinomycetemcomitans or Porphyromonas gingivalis, are known to increase the expression
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of cytokines through activation of the inflammasome complex, and consequently boost
osteoclastic activity, loosening implants [41]. Most studies use in vitro sterile inflammation
by Gram-negative endotoxin LPS, probably because it is very common and easily obtain-
able, and the most relevant source for peri-implantitis study is Porphyromonas gingivalis. As
dental implants are progressively considered go-to treatments for tooth loss, the use of LPS
sterile inflammation is paramount in order to mimic a peri-implantitis environment for
in vitro evaluation of which types or concentrations of implant particles could escalate the
inflammatory process, affecting implant tissue surroundings over time.
Therefore, the primary focus of this in vitro study is on assessing the effect of titanium
(TiO2) and zirconia (ZrO2) implant microparticles on the macrophage cytotoxicity and
inflammatory stimulating cytokine expression over time. A dental glass (ionomer filling
material) was also included in the experimental evaluation as a control, as it is an inert
material known for its low (inert) chemical or biological reactivity. In addition, TiO2 and
ZrO2 were also simultaneously employed in a sterile inflammation with endotoxin Por-
phyromonas gingivalis LPS in order to assess the possible surge expression of inflammatory
cytokines. We show that cell toxicity enhancement may be caused by increased TiO2 and
ZrO2 concentrations in the cell growth medium, and the LPS may have a synergistic effect
on the pro-inflammatory reaction over time.
2. Materials and Methods
2.1. Cell Culture
Human immortalized monocyte-like leukemia THP-1 cells (ATCC® TIB-202™; Ameri-
can Type Culture Collection, Manassas, VA, USA) were placed in a 6-well plate
(5 × 105 cells/well) with RPMI-1640 medium (Roswell Park Memorial Institute, Sigma-
Aldrich, Schaffhausen, Switzerland), supplemented with 10% fetal bovine serum and 1%
penicillin-streptomycin antibiotics (Invitrogen, Carlsbad, CA, USA) in an incubator with 5%
CO2/95% air at 37
◦C. The THP-1 cells were differentiated to macrophages using phorbol
12-myristate 13-acetate (PMA, Sigma Aldrich, St. Louis, MO, USA), followed by 24 h
incubation in RPMI medium.
2.2. Titanium, Zirconium and Glass Microparticles
Commercially pure particles of titanium (IV) dioxide microparticles (TiO2, CAS 13463-
67-7, <5 µm particle size, Sigma Aldrich, St. Louis, MO, USA) and zirconium (IV) dioxide
microparticles (ZrO2, CAS 131423-4, <5 µm size, Sigma Aldrich, St. Louis, MO, USA) were
used in this study. Inert glass ionomer filling material particles (55 wt% SiO2, 10 wt% Al2O3,
10 wt% B2O3 and 25 wt% BaO, Schott AG, Mainz, Germany, ident. no: 642905106, lot: M
92605, mean particle size of D50 ≈ 5 µm) were also used as controls [48,49]. Glass particles
were kindly donated by Dr. D. Mohn from the Department of Chemistry and Applied
Biosciences, Institute for Chemical and Bioengineering, ETH, University of Zurich. Particles
of TiO2, ZrO2 and glass were suspended in ultrapure water and filtered with Millipore
filters (Millipore Sigma, Burlington, MA, USA) to a final concentration of 1 mg/mL (stock
suspension) in order to obtain particles in a phagocytable range (2–5 µm). The suspensions
were prepared by 10 min sonication in an ultrasonic water bath (Sonores Super RK 156 BH,
Berlin, Germany) and vortexed for 30 s at full speed. The particles were cleaned using
25% nitric acid for 2 h, followed by 3 washes in 1× phosphate-buffered saline (Invitrogen,
Waltham, MA, USA) for 5 min each and placed in 95% ethanol with 0.1 N of NaOH for
24 h, followed by 3 washes in 1× phosphate buffered saline (PBS). Cells were exposed to
different particle concentrations in cell cultivation medium, but the same particle number
concentrations of TiO2 and ZrO2 particles was added to the cultured cells. The calculation
of the relation between particle mass and particle number concentration was performed
and described elsewhere [50]. The ratio between particle number concentration to particle
mass concentration was estimated, and the final particle mass concentration was different
for the two particle types. Following calculations, the particle number concentrations of
1 × 107, 1 × 108 and 1 × 109 particles/mL represented particle mass concentrations of
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0.876, 8.58 and 89.9 µg/mL for TiO2 particles and 0.912, 9.11 and 92.6 µg/mL for ZrO2
particles, respectively.
2.3. Macrophage Differentiation and Particle/LPS Stimulation
For experiments, cells were seeded in 24-well plates at a density of 1 × 105 cells/cm2
in a final volume of 1 mL. To differentiate monocytes toward macrophage phenotype,
cells were cultivated for 3 days in complete media supplemented with 100 nM phorbol
12-myristate 13-acetate (PMA, Sigma-Aldrich, St. Louis, MO, USA), followed by 24 h
cultivation under PMA-free conditions. For the cell viability, THP-1 cells were treated with
particle number concentrations of 1 × 107, 1 × 108 and 1 × 109, representing mass concen-
trations of 0.876, 8.58 and 89.9 µg/mL for TiO2 and 0.912, 9.11 and 92.6 µg/mL for ZrO2
particles in complete culture medium for 12, 24 and 48 h. Therefore, for the cell viability,
the particles were analyzed at concentrations between 0 and 100 µg/mL according to the
corresponding particle mass concentration applied during experimentation. Concentration-
dependent analysis revealed that 1 × 108 and 1 × 109 particles/mL confirmed adverse
toxicity effects on macrophages’ viability. Consequently, the particle number concentration
of 1 × 107 particles/mL was finally sublethal, and for this reason, was selected for the gene
expression assays. In order to assess particle-induced pro-inflammatory gene expression in
THP-1 after 12, 24 and 48 h of stimulation by the different particles TiO2, ZrO2 and glass
(at particle number concentration of 107 particles/mL), cell culture lysates were collected,
immediately centrifuged, transferred to a fresh tube and stored at −80 ◦C until used for
RT-PCR assays. Lipopolysaccharides from Porphyromonas gingivalis (P. gingivalis LPS) were
purchased from Sigma-Aldrich. Cells were cultured at 37 ◦C under 5% CO2 with 1 µg/mL
of P. gingivalis LPS for 24 h. The growth medium was then replaced with 100 µL of RPMI
1640 medium containing the TiO2, ZrO2 and glass particles at the 10
7 particles/mL concen-
trations. Cells were exposed to these agents for a further 48 h to finalize the experiment.
Macrophages cultured under particle-free/LPS conditions were used as negative controls.
2.4. Cell Viability Assay
To assess the potential influence of TiO2, ZrO2 and glass microparticles on in vitro cytotox-
icity, we performed a tetrazolium (MTT; (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide, Sigma–Aldrich) dye reduction assay (5 mg/mL in 1× PBS) according to the
manufacturer’s instructions. Briefly, monocytes were seeded in 96-well plates at a den-
sity of 105 cells/cm2 in a final volume of 200 µL and differentiated to macrophages, as
described above. Cells were treated for 12, 24 and 48 h with concentrations of 107, 108
and 109 particles/mL of TiO2, ZrO2 and glass. Negative control cells were cultured under
particle-free conditions. After particle stimulation, MTT reagent was added to the cell cul-
ture for 1 h, and the concentration of the soluble reduced formazan product was recorded
by a light absorbance spectrophotometer reader at 490 nm, and reference absorbance at
630 nm (Biotek Instruments Elx 800, Witec AG, Sursee, Switzerland).
2.5. Gene Expression Analysis
Gene expression analysis was performed by real-time polymerase chain reaction
(qRT-PCR) to assess expression levels of defined sets of genes after particle stimulation of
the cells. Total RNA was extracted from the cells after particle (107 particles/mL of TiO2,
ZrO2 and glass) and P. gingivalis LPS (1 µg/mL) stimulation by using the RNeasy MicroKit
(Qiagen, Hilden, Germany). The quality and quantity of the isolated RNA was analyzed
using a NanoDrop ND1000 spectrophotometer (Thermo Scientific, Basel, Switzerland).
Complementary DNA (cDNA) was synthesized in a volume of 20 µL from 300 ng of total
RNA using the iScript cDNA Synthesis Kit (Bio-Rad, Cressier, Switzerland). qRT-PCR
reaction was performed using TaqMan’s One-Step Master Mix kit (Applied Biosystems)
and specific primers (purchased from Microsynth, Switzerland) for TNF-α (forward: 5′-CCG
TCT CCT ACC AGA CCA AG-3′, reverse: 5′-CTG AGT CGG TCA CCC TTC TC-3′), IL-1β
(forward: 5′-ACA GAT GAA GTG CTC CTT CCA-3′, reverse: 5′-GTC GGA GAT TCG
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TAG CTG GAT-3′) and IL-6 (forward: 5′-GGT ACA TCC TCG ACG GCA TCT-3′, reverse:
5′-GTG CCT CTT TGC TGC TTT CAC-3′). The comparative Ct method (2−∆∆CT formula)
was used to calculate gene expression levels relative to the housekeeping gene GAPDH
(forward: 5′-GCT CTC TGC TCC TCC CTG TT-3′, reverse: 5′-CAC ACC GAC CTT CAC
CAT CT-3′) and normalized to control cells (with no particles). All samples were tested in
triplicate, and 3 independent experiments were performed. The results were presented as
means ± standard deviations.
2.6. Statistical Analysis
The mean values and standard deviations were computed for the MTT test, and a
multiple comparison analysis of variance (ANOVA) with Bonferroni adjustment with a
global significance level of 5% was conducted to assess the statistical significance of the
differences between the experimental groups using IBM SPSS software (IBM SPSS Statistics
for Windows, version 23.0; IBM Corp., Armonk, NY, USA). Differences were considered
significant at p ≤ 0.05, and all experiments were performed in triplicate and repeated at
least three times under the same conditions.
3. Results
3.1. Effect of Particles on Cell Viability
To investigate the influence of different concentrations of TiO2, ZrO2 and inert glass
microparticles on cell viability, we determined the cytotoxicity of these particles in various
particle concentrations of 107, 108 and 109 particles/mL using the MTT assay on the cultures
of phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 cells. After 12, 24 and 48 h
of exposure, macrophage viability was significantly reduced when exposed to higher
concentrations of TiO2 and ZrO2 particles (≥10
7) compared to the untreated negative
controls and glass (p < 0.05). However, at concentration ≤ 107, all three particles showed no
cytotoxicity effect in this cell culture assay (Figure 1). Increased cytotoxicity of glass at high
concentrations ≥ 107 particles/mL is similar to TiO2 and ZrO2 at 12, 24 and 48 h; however,
all particles are less cytotoxic at concentrations ≤ 107 after 48 h of application. The particle
concentration of 107 was selected for further gene expression analysis since enhanced gene
expression was detected in the samples with reduced cytotoxicity or sub-toxic conditions.
3.2. Particle-Induced Pro-Inflammatory Gene Expression in Macrophage Cultures Over Time
To obtain a cytokine expression profile as a function of TiO2, ZrO2 and glass particles
on differentiated macrophages, we performed a gene expression analysis of inflammatory
molecules over a period of time. Differentiated macrophages exposed to the 107 parti-
cles/mL concentration for 12, 24 and 48 h were analyzed toward pro-inflammatory pheno-
type. Relative expression levels of selected marker gene sets consisting of cytokines (TNF-α,
IL-1β and IL-6) were assessed. Results were set in relation to differentiated macrophages cul-
tured under particle-free conditions as negative controls. Cultured macrophages challenged
with TiO2 and ZrO2 particles expressed an increase in mRNA for inflammatory cytokines
TNF-α, IL-1β and IL-6 (up to ≈3.5-fold upregulated) at 12, 24 and 48 h (Figure 2A–C, as
indicated by the symbol *). However, compared to TiO2, ZrO2 particles and glass produced
a significantly lower increase of pro-inflammatory gene expression (p < 0.05), and glass par-
ticles presented an even lower effect compared to TiO2 and ZrO2. There was a statistically
significant interaction between material and time (p < 0.05).
3.3. Particle and Sterile LPS Inflammation-Induced Pro-Inflammatory Gene Expression
Particles were used at a non-toxic 107 particles/mL concentration. Cytokines’ expres-
sion was more enhanced under exposure to TiO2 in comparison to the control (p < 0.001).
No significance was found between control and glass (p > 0.05), and the exposure to TiO2
caused higher upregulation than to ZrO2 (p < 0.001). This effect was dependent on the
type of particle as, for instance, TiO2 presented higher expression of inflammatory genes
compared to ZrO2 or glass particles (p < 0.05). Adding P. gingivalis LPS (1 µg/mL) to the
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THP-1 cells for 24 h (before exposure to TiO2, ZrO2 and glass particles) caused an up to
6-fold increase in TNF-α (Figure 3A), IL-1β (Figure 3B) and IL-6 expression (Figure 3C) in
comparison to the control (p < 0.001). After an additional 24 h exposure to P. gingivalis
LPS, a statistically significant higher secretion of TNF-α, IL-1β and IL-6 was found in cells
exposed to particles of TiO2 or ZrO2 in comparison to LPS treatment alone (p < 0.001).
However, between TiO2 and ZrO2, no difference was found in this expression with the
addition of LPS (p > 0.05).




Figure 1. Evaluation of cellular viability (MTT assay). Cytotoxicity of human macrophages (THP-1) 
over 12, 24 and 48 h for the untreated control (Ctrl), glass, titanium (TiO2) and zirconia (ZrO2) par-
ticles at 109, 108 and 107 particles/mL concentrations in medium. Results are presented as percent of 
control (mean ± SD) from three independent experiments. * p ≤ 0.05, ** p ≤ 0.001, ns: No statistical 
differences were detected using one-way ANOVA. 
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molecules over a period of time. Differentiated macrophages exposed to the 107 parti-
cles/mL concentration for 12, 24 and 48 h were analyzed toward pro-inflammatory phe-
notype. Relative expression levels of selected marker gene sets consisting of cytokines 
(TNF-α, IL-1β and IL-6) were assessed. Results were set in relation to differentiated mac-
rophages cultured under particle-free conditions as negative controls. Cultured macro-
phages challenged with TiO2 and ZrO2 particles expressed an increase in mRNA for in-
flammatory cytokines TNF-α, IL-1β and IL-6 (up to 3.5-fold upregulated) at 12, 24 and 48 
Figure 1. Evaluation of cellular viability (MTT assay). Cytotoxicity of human macrophages (THP-1)
over 12, 24 and 48 h for the untreated control (Ctrl), glass, titanium (TiO2) and zirconia (ZrO2)
particles at 109, 108 and 107 particles/mL concentrations in medium. Results are presented as percent
of control (mean ± SD) from three independent experiments. * p ≤ 0.05, ** p ≤ 0.001, ns: No statistical
differences were detected using one-way ANOVA.
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Figure 2. Particle-induced pro-infla atory gene expression in THP-1 over time. Expression of
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nia, ZrO2 (), and glass (•) particles (10
7 particles/mL concentration). qRT-PCR, with normalization
to GAPDH using the Ct method analysis, are shown as means ± SD. (A) TNF-α, (B) IL-1β, (C)
IL-6. The symbol * indicates a statistically significant increase in cytokines’ mRNA expression in
comparison to non-challenged macrophages. There is a statistically significant interaction between
time and material in all cases (two-way repeated measure ANOVA). * p ≤ 0.05.
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Figure 3. Particle and sterile LPS inflammation-induced pro-i fl i i -1.
Expression of mRNA for inflammatory cytokines in macrophages challenged with titanium (TiO2),
zirconia (ZrO2) and glass particles under sterile inflammation (LPS = 1 µg/mL) in 48 h. qRT-PCR,
with normalization to GAPDH using the Ct method analysis, are shown as means ± SD. (A) TNF-α,
(B) IL-1β, (C) IL-6. The symbol * indicates a statistically significant increase in cytokines’ mRNA
expression in comparison to non-challenged macrophages. * p ≤ 0.05.
4. Discussion
The history of implant development shows that throughout the years, much has
been improved on implant biomaterial properties and their surfaces. Microscopic implant
material wear debris or particles may still be produced by shear forces and abrasion
during implant placement, which could steer an inflammatory process, bone loss and
subsequent clinical complications [38]. In fact, titanium wear particles have been associated
with the establishment of inflammation by stimulating macrophage response [38,39,48],
which may be exacerbated by the presence of periodontal bacteria [40,41]. A metal-free
implant material alternative to titanium was also proposed for prosthetic rehabilitation, but
zirconia wear particles might further affect macrophage stimulation and have not yet been
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researched in detail. This study attempts to synthetize the effect of different concentrations
of TiO2 and ZrO2 microparticles on human macrophage response. Another purpose of
this study was to examine the particles’ combined effect with P. gingivalis LPS as a potent
endotoxin pathogen for inflammation in peri-implantitis disease.
The findings showed that glass, TiO2 and ZrO2 particles in higher concentrations
presented a detrimental effect on the macrophage cell viability when compared with the
respective negative control groups, and that was independent of time exposure. In fact, this
concentration-dependent analysis with cell viability evaluation showed that cytotoxicity
was not affected at the 107 particles/mL concentration. Therefore, this particle number
concentration was also selected as the ideal sublethal concentration for further gene expres-
sion assays. As confirmed previously, an increase in the gene expression can be measured
when TiO2 particles are applied in non-cytotoxic doses [40]. The cell viability assessment
presented here is confirmed by previous analyses on cell toxicity of TiO2 [38–42,51,52] and
ZrO2 particles [38]. Similar negative effects were previously shown for human THP-1 cells,
which demonstrated higher cytoplasmatic assimilation of nanoparticles within 24 h of
exposure [53,54]. As predicted and supported by the literature [55], no reduction in number
of viable cells was observed with the tested inert glass when exposed to non-cytotoxic con-
centrations. The cell viability was further complemented by challenging macrophages with
TiO2 and ZrO2 particles, which finally induced overtime upregulation of pro-inflammatory
cytokines TNF-α, IL-1β and IL-6. These cytokines are key molecules in bone remodeling,
and enhanced levels of these molecules are commonly found in tissue fluids of degenera-
tive diseases, such as periodontitis and peri-implantitis [43]. In addition, the data showed
that stimulation of LPS intensified the cytokine expression even more. However, noticeable
quantitative gene expression differences between TiO2 and ZrO2 was observed, as TiO2
particle exposure promoted higher pro-inflammatory gene expression than ZrO2 particles
in macrophages. This could be explained by the fact that macrophages’ uptake of TiO2
particles is more effective than ZrO2 particles, which thereby would effectively stimulate
the acute activation of an inflammatory gene expression program [51]. The amounts of
cytokines were significantly increased for TiO2 and ZrO2 compared to unstimulated cells.
However, the amounts of cytokines from LPS-stimulated cells were slightly lower in the
presence of glass compared to the control stimulated with LPS. This result corroborates
previous studies by showing the potential antibacterial ability of these glasses to inhibit
the secretion of inflammatory cytokines in the presence of an inflammatory stimulus such
as LPS Gram-negative bacteria [41,55,56]. The obtained data also confirms earlier research
that elucidates the effect of TiO2 particles associated with P. gingivalis LPS34.
Within the limitations of the present study, we hypothesize that soluble LPS could
bind and accumulate on the titanium and zirconia particles from implant insertion debris
to induce an inflammatory response, since dissolved LPS and its lipid A-active group
may be freely available for macrophage activation in the surrounding implant tissues.
It should also be noted, however, that only the response of the THP-1 macrophage cell
line was tested here. Future studies are still necessary to compare the response of other
cell types of human origin to LPS sterile-induced inflammation not only with titanium
or zirconia, but also with other implant or abutment materials. Moreover, nanoparticles
and/or micro-particles influence assessment on peri-implant supporting bone destruction
is still necessary, especially during early stages of osteointegration. Our present findings
support theories for the cause of peri-implantitis which suggest that inflammation is
induced not only by microbes, but also by foreign-body reactions to implant material [8,55].
In summary, within constraints, the results provide evidence that titanium and zirconia
microparticles may prompt macrophage cytotoxicity by increasing their concentration,
and their induced proinflammatory effect can be exacerbated by the presence of LPS in
the medium. Additionally, the findings suggest that compared to TiO2 particles, ZrO2
particles caused reduced toxicity and inflammatory cytokine production. Further studies
are necessary to determine whether these responses are likely to be the same in vivo.
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